DK3436463T3 - Krystalline former af 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-on hemi-hydrat - Google Patents
Krystalline former af 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-on hemi-hydrat Download PDFInfo
- Publication number
- DK3436463T3 DK3436463T3 DK17719053.5T DK17719053T DK3436463T3 DK 3436463 T3 DK3436463 T3 DK 3436463T3 DK 17719053 T DK17719053 T DK 17719053T DK 3436463 T3 DK3436463 T3 DK 3436463T3
- Authority
- DK
- Denmark
- Prior art keywords
- thieno
- hemi
- azabicyclo
- pyrazol
- pyrimidin
- Prior art date
Links
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662314080P | 2016-03-28 | 2016-03-28 | |
| US201662367842P | 2016-07-28 | 2016-07-28 | |
| PCT/US2017/024226 WO2017172565A1 (en) | 2016-03-28 | 2017-03-27 | Crystalline forms of 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h- pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-one hemihydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3436463T3 true DK3436463T3 (da) | 2021-08-30 |
Family
ID=58609973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17719053.5T DK3436463T3 (da) | 2016-03-28 | 2017-03-27 | Krystalline former af 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-on hemi-hydrat |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11746109B2 (da) |
| EP (1) | EP3436463B1 (da) |
| JP (2) | JP6918824B2 (da) |
| CN (1) | CN108779126B (da) |
| CA (1) | CA3016708A1 (da) |
| DK (1) | DK3436463T3 (da) |
| ES (1) | ES2884398T3 (da) |
| PL (1) | PL3436463T3 (da) |
| PT (1) | PT3436463T (da) |
| TW (1) | TWI738748B (da) |
| WO (1) | WO2017172565A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112018012914B1 (pt) | 2015-12-22 | 2023-04-18 | SHY Therapeutics LLC | Composto, uso de um composto e composição farmacêutica |
| PL3436463T3 (pl) * | 2016-03-28 | 2021-11-08 | Takeda Pharmaceutical Company Limited | Postaci krystaliczne półwodzianu 2-[(2s)-1-azabicyklo[2.2.2]okt-2-ylo]-6-(3-metylo-1h-pirazol-4-ilo)tieno[3,2-d]pirymidyn-4(3h)-onu |
| CN112409373A (zh) * | 2017-05-21 | 2021-02-26 | 南京正济医药研究有限公司 | 作为抗癌剂的取代的[5,6]环-4(3h)-嘧啶酮 |
| EP4331679A3 (en) | 2017-06-21 | 2024-04-03 | Shy Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| CN111989331B (zh) * | 2018-04-02 | 2024-04-12 | 武田药品工业株式会社 | 2-[(2S)-1-氮杂双环[2.2.2]辛-2-基]-6-(3-甲基-1H-吡唑-4-基)噻吩并[3,2-d]嘧啶-4(3H)-酮的合成方法 |
| TWI846703B (zh) * | 2018-06-19 | 2024-07-01 | 日商武田藥品工業股份有限公司 | 癌症治療方法 |
| JP7387710B2 (ja) * | 2018-07-19 | 2023-11-28 | 武田薬品工業株式会社 | Ｃｄｃ７阻害剤を含む医薬組成物 |
| EP3898609A1 (en) | 2018-12-19 | 2021-10-27 | Shy Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| JP2022534316A (ja) * | 2019-05-30 | 2022-07-28 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド | Ｃｄｃ７阻害剤としての四環式化合物 |
| MA56550A (fr) * | 2019-06-24 | 2022-04-27 | Naurex Inc | Formes solides de tert-butyl (s)-2-((2s,3r)-1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo -2, 5-diazaspiro[3,4]octane-5-carboxylate et leurs procédés de préparation |
| WO2021015294A2 (en) | 2019-07-19 | 2021-01-28 | Takeda Pharmaceutical Company Limited | Combination therapy for cancer treatment |
| US20240025920A1 (en) * | 2020-11-30 | 2024-01-25 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Salt form used as cdc7 inhibitor and crystal form thereof |
| US20240173323A1 (en) | 2021-02-08 | 2024-05-30 | Takeda Pharmaceutical Company Limited | Combination therapy for cancer treatment |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2540728T1 (sl) | 2010-02-17 | 2019-06-28 | Takeda Pharmaceutical Company Limited | Heterociklična spojina |
| PL3436463T3 (pl) * | 2016-03-28 | 2021-11-08 | Takeda Pharmaceutical Company Limited | Postaci krystaliczne półwodzianu 2-[(2s)-1-azabicyklo[2.2.2]okt-2-ylo]-6-(3-metylo-1h-pirazol-4-ilo)tieno[3,2-d]pirymidyn-4(3h)-onu |
-
2017
- 2017-03-27 PL PL17719053T patent/PL3436463T3/pl unknown
- 2017-03-27 US US16/088,096 patent/US11746109B2/en active Active
- 2017-03-27 JP JP2018550532A patent/JP6918824B2/ja active Active
- 2017-03-27 EP EP17719053.5A patent/EP3436463B1/en active Active
- 2017-03-27 DK DK17719053.5T patent/DK3436463T3/da active
- 2017-03-27 CA CA3016708A patent/CA3016708A1/en active Pending
- 2017-03-27 TW TW106110102A patent/TWI738748B/zh active
- 2017-03-27 CN CN201780018847.4A patent/CN108779126B/zh active Active
- 2017-03-27 PT PT177190535T patent/PT3436463T/pt unknown
- 2017-03-27 WO PCT/US2017/024226 patent/WO2017172565A1/en not_active Ceased
- 2017-03-27 ES ES17719053T patent/ES2884398T3/es active Active
-
2020
- 2020-04-27 JP JP2020078643A patent/JP2020143076A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2884398T3 (es) | 2021-12-10 |
| PT3436463T (pt) | 2021-09-06 |
| CA3016708A1 (en) | 2017-10-05 |
| JP2020143076A (ja) | 2020-09-10 |
| JP6918824B2 (ja) | 2021-08-11 |
| JP2019510033A (ja) | 2019-04-11 |
| CN108779126B (zh) | 2021-07-16 |
| PL3436463T3 (pl) | 2021-11-08 |
| EP3436463A1 (en) | 2019-02-06 |
| TW201736383A (zh) | 2017-10-16 |
| TWI738748B (zh) | 2021-09-11 |
| US20230102273A1 (en) | 2023-03-30 |
| EP3436463B1 (en) | 2021-06-23 |
| WO2017172565A1 (en) | 2017-10-05 |
| CN108779126A (zh) | 2018-11-09 |
| US11746109B2 (en) | 2023-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3436463T3 (da) | Krystalline former af 2-[(2s)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1h-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3h)-on hemi-hydrat | |
| FR22C1006I2 (fr) | Derives de pyrrolo-[2,3-d]pyrimidine en tant qu'inhibiteurs des janus kinases (jak) | |
| IL266897B (en) | History of thiano[2,3–d]pyrimidines for the treatment of viral infections | |
| LT3555097T (lt) | Imidazo[4,5-d]pirolo[2,3-b]piridino junginiai kaip janus kinazės inhibitoriai | |
| PL3345907T3 (pl) | Związki pirazolo[3,4-d]pirymidynowe lub ich sole | |
| MA46054A (fr) | Procédé de préparation de pyrazolo[1,5-a]pyrimidines et de sels de celles-ci | |
| DK3133035T3 (da) | Adsorptionskop af typen med aftagelig griber | |
| SI3693367T1 (sl) | Tieno(3,2-D)pirimidini, uporabni za zdravljenje okužb z respiratornim sincicijskim virusom | |
| EP3452481A4 (en) | IMIDAZO [1,2-B] SUBSTITUTED PYRIDAZINES, IMIDAZO [1,5-B] SUBSTITUTED PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS | |
| DK3287460T3 (da) | Hemisulfatsalt af 5,10-methylen-(6r)-tetrahydrofolsyre | |
| EP3096762C0 (en) | PYRAZOLO[1,5-A]PYRIMIDINES AS ANTIVIRAL COMPOUNDS | |
| DK3400225T3 (da) | Pentansyrederivater substitueret med pyrrolo-[2,3-b]pyrimidinpyridiner til behandling af influenzavirusinfektioner | |
| EP3472169A4 (en) | PROCESS FOR PREPARING 4-CHLORO-7H-PYRROLO [2,3-D] PYRIMIDINE | |
| ZA201701814B (en) | Triazolo[4,5-d]pyrimidines as agonists of the cannabinoid receptor 2 | |
| EP3489342A4 (en) | SIPHONE-LIKE CULTIVATION PROCESS | |
| EP3456324A4 (en) | METHOD FOR PRODUCING AN ACET AMINOPHIC PREPARATION | |
| EP3383219A4 (en) | SMART LUXURY CLOCK | |
| FR3048968B1 (fr) | Procede de preparation d'alkylamines | |
| MA46937A (fr) | 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones en tant qu'inhibiteurs de kinases dépendantes des cyclines | |
| EA201692482A1 (ru) | Способы лечения заболеваний антителами, которые связывают рецептор колониестимулирующего фактора 1 (csf1r) | |
| DK3362453T3 (da) | Cykliske etherderivater af pyrazolo[1,5-a]pyrimidin-3-carboxyamid | |
| HUE046116T2 (hu) | Biotin, demielinizációs neuropátiák kezelésére | |
| EP3466381A4 (en) | METHOD OF PREPARING VOIDABLE ARTICLES | |
| DK3459953T3 (da) | Hidtil ukendt 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-on-derivat | |
| FR3049599B1 (fr) | Procede de preparation de l'hexafluorobutadiene. |